Cargando…

MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin

Purpose: Several microRNAs (miRNAs) that are aberrantly expressed in glioblastoma multiforme (GBM) play a significant role in GBM formation and progression. The expression profile and functions of miR-559 in GBM remain unclear. Here, we quantified the expression and investigated the involvement of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Zhang, Chuangang, Xu, Congbin, Fu, Fangyou, Han, Dong, Li, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556469/
https://www.ncbi.nlm.nih.gov/pubmed/31239710
http://dx.doi.org/10.2147/OTT.S202309
_version_ 1783425331396345856
author Yang, Fan
Zhang, Chuangang
Xu, Congbin
Fu, Fangyou
Han, Dong
Li, Hongliang
author_facet Yang, Fan
Zhang, Chuangang
Xu, Congbin
Fu, Fangyou
Han, Dong
Li, Hongliang
author_sort Yang, Fan
collection PubMed
description Purpose: Several microRNAs (miRNAs) that are aberrantly expressed in glioblastoma multiforme (GBM) play a significant role in GBM formation and progression. The expression profile and functions of miR-559 in GBM remain unclear. Here, we quantified the expression and investigated the involvement of miR-559 in the oncogenicity of GBM cells in vitro and in vivo. Material and methods: Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) was carried out to determine miR-559 expression in GBM tissues and cell lines. A series of functional assays was performed to evaluate the effects of miR-559 overexpression on GBM cell proliferation, apoptosis, migration, and invasion in vitro and on GBM tumor growth in vivo. The regulatory mechanisms of miR-559 action in GBM cells were then explored. Results: The expression of miR‑559 was lower in GBM tissues and cell lines and significantly correlated with the Karnofsky performance score and tumor size among patients with GBM. Exogenous miR‑559 expression inhibited GBM cell proliferation, migration, and invasion and promoted apoptosis. MiR-559 overexpression decreased tumor growth in vivo. Mechanistic experiments confirmed metadherin (MTDH) as a direct target gene of miR-559 in GBM. Silencing of MTDH induced effects similar to those of miR-559 upregulation in GBM cells, whereas MTDH expression restoration attenuated the antitumor effects of miR‑559 in GBM cells. Protein kinase B (AKT) in the phosphatase and tensin homolog (PTEN)–AKT signaling pathway was found to be deactivated in GBM cells after upregulation of miR-559 both in vitro and in vivo. Conclusion: MiR-559 acts as a tumor suppressor in GBM cells in vitro and in vivo, at least in part through the downregulation of MTDH and inhibition of AKT in the PTEN–AKT pathway. Therefore, targeting the miR-559–MTDH axis may be a promising therapeutic strategy for patients with GBM.
format Online
Article
Text
id pubmed-6556469
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65564692019-06-25 MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin Yang, Fan Zhang, Chuangang Xu, Congbin Fu, Fangyou Han, Dong Li, Hongliang Onco Targets Ther Original Research Purpose: Several microRNAs (miRNAs) that are aberrantly expressed in glioblastoma multiforme (GBM) play a significant role in GBM formation and progression. The expression profile and functions of miR-559 in GBM remain unclear. Here, we quantified the expression and investigated the involvement of miR-559 in the oncogenicity of GBM cells in vitro and in vivo. Material and methods: Reverse-transcription quantitative polymerase chain reaction (RT-qPCR) was carried out to determine miR-559 expression in GBM tissues and cell lines. A series of functional assays was performed to evaluate the effects of miR-559 overexpression on GBM cell proliferation, apoptosis, migration, and invasion in vitro and on GBM tumor growth in vivo. The regulatory mechanisms of miR-559 action in GBM cells were then explored. Results: The expression of miR‑559 was lower in GBM tissues and cell lines and significantly correlated with the Karnofsky performance score and tumor size among patients with GBM. Exogenous miR‑559 expression inhibited GBM cell proliferation, migration, and invasion and promoted apoptosis. MiR-559 overexpression decreased tumor growth in vivo. Mechanistic experiments confirmed metadherin (MTDH) as a direct target gene of miR-559 in GBM. Silencing of MTDH induced effects similar to those of miR-559 upregulation in GBM cells, whereas MTDH expression restoration attenuated the antitumor effects of miR‑559 in GBM cells. Protein kinase B (AKT) in the phosphatase and tensin homolog (PTEN)–AKT signaling pathway was found to be deactivated in GBM cells after upregulation of miR-559 both in vitro and in vivo. Conclusion: MiR-559 acts as a tumor suppressor in GBM cells in vitro and in vivo, at least in part through the downregulation of MTDH and inhibition of AKT in the PTEN–AKT pathway. Therefore, targeting the miR-559–MTDH axis may be a promising therapeutic strategy for patients with GBM. Dove 2019-06-05 /pmc/articles/PMC6556469/ /pubmed/31239710 http://dx.doi.org/10.2147/OTT.S202309 Text en © 2019 Yang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yang, Fan
Zhang, Chuangang
Xu, Congbin
Fu, Fangyou
Han, Dong
Li, Hongliang
MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin
title MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin
title_full MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin
title_fullStr MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin
title_full_unstemmed MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin
title_short MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin
title_sort microrna-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556469/
https://www.ncbi.nlm.nih.gov/pubmed/31239710
http://dx.doi.org/10.2147/OTT.S202309
work_keys_str_mv AT yangfan microrna559playsaninhibitoryroleinthemalignantprogressionofglioblastomacellsbydirectlytargetingmetadherin
AT zhangchuangang microrna559playsaninhibitoryroleinthemalignantprogressionofglioblastomacellsbydirectlytargetingmetadherin
AT xucongbin microrna559playsaninhibitoryroleinthemalignantprogressionofglioblastomacellsbydirectlytargetingmetadherin
AT fufangyou microrna559playsaninhibitoryroleinthemalignantprogressionofglioblastomacellsbydirectlytargetingmetadherin
AT handong microrna559playsaninhibitoryroleinthemalignantprogressionofglioblastomacellsbydirectlytargetingmetadherin
AT lihongliang microrna559playsaninhibitoryroleinthemalignantprogressionofglioblastomacellsbydirectlytargetingmetadherin